Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by consultant99on Dec 19, 2019 11:10am
135 Views
Post# 30472598

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Common vs Warrants.....

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Common vs Warrants.....

I know a lot of investors and some of them have multi-million dollar portfolios. The vast majority of them have eyes that would gloss over whenever someone tried to explain options and warrants to them. I have come to realize that it is not intuitive for a lot of people to want to buy warrants because they lack understanding or they purceive them to be too risky.

in the case of TLT when Mackie evaluated the Offering at 0.30/share a value of 0.23 was assigned to the shares and 0.07 for the warrants presumably on the basis of a BS model. In the early days the warrants gained value and quickly started to trade above what might be called "fair value" based on the model.

Do while I was very interested in the warrants I was also weary as to how they would trade and how they would react to changes in the common shares. Currently the warrants have no intrinsic value because the common shares are below the 0.35 warrant exercise price - all the value is in the time premium.

What I have leaned from options trading is that there is fair value and market value so in the case of the warrants even though the warrants are trading above fair value the reality is that if you want to own them today you have to pay up. That is the best indicator that there are a lot of interested investors in the warrants and that their expectations are the common shares will rise well above the warrant exercise price within the life of the warrant - the next 4 1/2 years.

Because the warrants have such a long life they appear to be trading in a rough ratio of 2 warrants per 1 common share. Above 0.70 per share for the common I expect that to change to the warrants trading at the common share price minus 0.35 plus some time value for the option.

With options the time value declines as you get closer to expiry or when the intrinsic value becomes significant; in the case of the warrants when the common shares start trading well above the 0.35/share exercise price.Regardless I would not expect to see the warrants trade for a discount greater than 0.35/share because of arbatrage opportunities to buy and exercise the warrants versus buying the common outright.

i agree that liquidity of the warrants is far less than the common shares and that is always a concern with options trading. There are however over 60 million warrants outstanding and that is plenty to ensure a liquid market.

That  said Liquidity could be a concern if I owned the warrants and wanted out when there is no intrinsic value. That is a risk if market sentiment changed for some reason or I just needed to cash out; there is no arbatriage when there is no intrinsic value in the warrants I.e. below a common price of 0.35/share.

The other risk with playing TLT just by utilizing the warrants is if there were some unexpected delay in getting regulatory approval before the warrants expire. That said the vast majority of investors believe the share price will be well above $0.70/share when the warrants expire.

As a previous poster commented, why not use both stock and warrants to invest in TLT? I totally agree and I have been periodically selling some shares to buy the warrants. I have reached my speculative & financial limits in investing in TLT so this is one way of acquiring more upside leverage at no additional cost.

Bullboard Posts